Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis

Chi Ruei Huang, Chung Ta Lee, Kwang Yu Chang, Wen Chang Chang, Yao Wen Liu, Jenq Chang Lee, Ben Kuen Chen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The aryl hydrocarbon receptor nuclear translocator (ARNT) is broadly involved in regulating tumorigenesis by inducing genes that are involved in tumor growth and angiogenesis. Tumorigenesis usually involves normoxic conditions. However, the role of ARNT in tumor metastasis during normoxia remains unclear. Here, we demonstrate that ARNT protein levels were decreased in late-stage human colorectal cancer using immunohistochemical analysis. Down-regulation of ARNT protein promoted cancer cell migration and invasion, which was mediated by activation of the fibronectin/integrin β1/FAK signaling axis. In addition, the enhancement of migration and invasion in ANRT knockdown cells was blocked when ARNT was restored in the cells. In xenografts in severe combined immunodeficiency mice, tumor growth was significantly inhibited in the ARNT-knockdown condition. However, the tail-vein injection animal model revealed that the depletion of ARNT-induced metastatic lung colonies was further enhanced when ARNT expression was recovered post-injection. Interestingly, chemotherapeutic drugs inhibited ARNT expression and promoted the invasion of residual tumor cells. These results suggest that ARNT may play a positive role during tumor growth (either in early-stage tumor growth or in organ metastases), but plays a negative role in tumor migration and invasion. Therefore, the efficiency of ARNT-targeted therapy during different cancer stages should be carefully evaluated.

Original languageEnglish
Pages (from-to)11530-11546
Number of pages17
JournalOncotarget
Volume6
Issue number13
Publication statusPublished - 2015

Fingerprint

Aryl Hydrocarbon Receptor Nuclear Translocator
Fibronectins
Integrins
Down-Regulation
Neoplasm Metastasis
Neoplasms
Growth
Nuclear Proteins
Carcinogenesis
Severe Combined Immunodeficiency
Injections
Residual Neoplasm
Heterografts
Cell Movement
Tail

Keywords

  • ARNT
  • Metastasis
  • Oncogene
  • ROS

ASJC Scopus subject areas

  • Oncology

Cite this

Huang, C. R., Lee, C. T., Chang, K. Y., Chang, W. C., Liu, Y. W., Lee, J. C., & Chen, B. K. (2015). Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis. Oncotarget, 6(13), 11530-11546.

Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis. / Huang, Chi Ruei; Lee, Chung Ta; Chang, Kwang Yu; Chang, Wen Chang; Liu, Yao Wen; Lee, Jenq Chang; Chen, Ben Kuen.

In: Oncotarget, Vol. 6, No. 13, 2015, p. 11530-11546.

Research output: Contribution to journalArticle

Huang, CR, Lee, CT, Chang, KY, Chang, WC, Liu, YW, Lee, JC & Chen, BK 2015, 'Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis', Oncotarget, vol. 6, no. 13, pp. 11530-11546.
Huang, Chi Ruei ; Lee, Chung Ta ; Chang, Kwang Yu ; Chang, Wen Chang ; Liu, Yao Wen ; Lee, Jenq Chang ; Chen, Ben Kuen. / Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis. In: Oncotarget. 2015 ; Vol. 6, No. 13. pp. 11530-11546.
@article{1385a053e17349f2b0a46a671cef11e2,
title = "Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis",
abstract = "The aryl hydrocarbon receptor nuclear translocator (ARNT) is broadly involved in regulating tumorigenesis by inducing genes that are involved in tumor growth and angiogenesis. Tumorigenesis usually involves normoxic conditions. However, the role of ARNT in tumor metastasis during normoxia remains unclear. Here, we demonstrate that ARNT protein levels were decreased in late-stage human colorectal cancer using immunohistochemical analysis. Down-regulation of ARNT protein promoted cancer cell migration and invasion, which was mediated by activation of the fibronectin/integrin β1/FAK signaling axis. In addition, the enhancement of migration and invasion in ANRT knockdown cells was blocked when ARNT was restored in the cells. In xenografts in severe combined immunodeficiency mice, tumor growth was significantly inhibited in the ARNT-knockdown condition. However, the tail-vein injection animal model revealed that the depletion of ARNT-induced metastatic lung colonies was further enhanced when ARNT expression was recovered post-injection. Interestingly, chemotherapeutic drugs inhibited ARNT expression and promoted the invasion of residual tumor cells. These results suggest that ARNT may play a positive role during tumor growth (either in early-stage tumor growth or in organ metastases), but plays a negative role in tumor migration and invasion. Therefore, the efficiency of ARNT-targeted therapy during different cancer stages should be carefully evaluated.",
keywords = "ARNT, Metastasis, Oncogene, ROS",
author = "Huang, {Chi Ruei} and Lee, {Chung Ta} and Chang, {Kwang Yu} and Chang, {Wen Chang} and Liu, {Yao Wen} and Lee, {Jenq Chang} and Chen, {Ben Kuen}",
year = "2015",
language = "English",
volume = "6",
pages = "11530--11546",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "13",

}

TY - JOUR

T1 - Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis

AU - Huang, Chi Ruei

AU - Lee, Chung Ta

AU - Chang, Kwang Yu

AU - Chang, Wen Chang

AU - Liu, Yao Wen

AU - Lee, Jenq Chang

AU - Chen, Ben Kuen

PY - 2015

Y1 - 2015

N2 - The aryl hydrocarbon receptor nuclear translocator (ARNT) is broadly involved in regulating tumorigenesis by inducing genes that are involved in tumor growth and angiogenesis. Tumorigenesis usually involves normoxic conditions. However, the role of ARNT in tumor metastasis during normoxia remains unclear. Here, we demonstrate that ARNT protein levels were decreased in late-stage human colorectal cancer using immunohistochemical analysis. Down-regulation of ARNT protein promoted cancer cell migration and invasion, which was mediated by activation of the fibronectin/integrin β1/FAK signaling axis. In addition, the enhancement of migration and invasion in ANRT knockdown cells was blocked when ARNT was restored in the cells. In xenografts in severe combined immunodeficiency mice, tumor growth was significantly inhibited in the ARNT-knockdown condition. However, the tail-vein injection animal model revealed that the depletion of ARNT-induced metastatic lung colonies was further enhanced when ARNT expression was recovered post-injection. Interestingly, chemotherapeutic drugs inhibited ARNT expression and promoted the invasion of residual tumor cells. These results suggest that ARNT may play a positive role during tumor growth (either in early-stage tumor growth or in organ metastases), but plays a negative role in tumor migration and invasion. Therefore, the efficiency of ARNT-targeted therapy during different cancer stages should be carefully evaluated.

AB - The aryl hydrocarbon receptor nuclear translocator (ARNT) is broadly involved in regulating tumorigenesis by inducing genes that are involved in tumor growth and angiogenesis. Tumorigenesis usually involves normoxic conditions. However, the role of ARNT in tumor metastasis during normoxia remains unclear. Here, we demonstrate that ARNT protein levels were decreased in late-stage human colorectal cancer using immunohistochemical analysis. Down-regulation of ARNT protein promoted cancer cell migration and invasion, which was mediated by activation of the fibronectin/integrin β1/FAK signaling axis. In addition, the enhancement of migration and invasion in ANRT knockdown cells was blocked when ARNT was restored in the cells. In xenografts in severe combined immunodeficiency mice, tumor growth was significantly inhibited in the ARNT-knockdown condition. However, the tail-vein injection animal model revealed that the depletion of ARNT-induced metastatic lung colonies was further enhanced when ARNT expression was recovered post-injection. Interestingly, chemotherapeutic drugs inhibited ARNT expression and promoted the invasion of residual tumor cells. These results suggest that ARNT may play a positive role during tumor growth (either in early-stage tumor growth or in organ metastases), but plays a negative role in tumor migration and invasion. Therefore, the efficiency of ARNT-targeted therapy during different cancer stages should be carefully evaluated.

KW - ARNT

KW - Metastasis

KW - Oncogene

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=84929629267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929629267&partnerID=8YFLogxK

M3 - Article

C2 - 25839165

AN - SCOPUS:84929629267

VL - 6

SP - 11530

EP - 11546

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 13

ER -